Photo by brookecagle from unsplash
This case report describes a woman aged 64 years with a history of multiple myeloma who presented with worsening vision after receiving an infusion of belantamab mafodotin. Click to show full abstract
This case report describes a woman aged 64 years with a history of multiple myeloma who presented with worsening vision after receiving an infusion of belantamab mafodotin.
Keywords:
hyperopic surprise;
chemotherapy induced;
induced hyperopic;
multiple myeloma;
woman
Journal Title: JAMA ophthalmology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JAMA ophthalmology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!